Australians line up at pharmacies for winter dose

On 11 July, 7.4 million Australians became eligible for a COVID-19 winter dose after the eligibility criteria widened.

Fluoxetine: can it decrease weight in obese and overweight patients?

This evidence summary presents the best available evidence on the effectiveness of fluoxetine in decreasing weight.

A better pharmacy experience leads to increased medicine adherence, study shows

There is a link between the perceived quality of care provided by community pharmacists and patients’ adherence to prescribed medicine, new Australian research has shown.

Have your voice heard with PSA’s Communities of Specialty Interest

Pharmacists across the country have a new way to connect, collaborate and drive the profession forward, with the launch of PSA’s Communities of Specialty Interest (CSIs).

What went right (and wrong) with Australia’s COVID-19 response?

COVID-19 enquiry criticises delays involving pharmacists in rollout, calling for urgent harmonisation of vaccine scope.

How to talk about smoking cessation in priority populations

Health advocate supporting smoking cessation in priority populations at the beach
Pharmacists can provide important information and support, recommend suitable over-the-counter products to help patients quit smoking.